4//SEC Filing
Davis Blaine 4
Accession 0001209191-20-051631
CIK 0001359931other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 9:20 AM ET
Size
5.1 KB
Accession
0001209191-20-051631
Insider Transaction Report
Form 4
Davis Blaine
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-09-22$16.91/sh+1,481$25,038→ 1,481 total
Footnotes (1)
- [F1]The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $16.885 to $16.935, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Documents
Issuer
Protara Therapeutics, Inc.
CIK 0001359931
Entity typeother
Related Parties
1- filerCIK 0001802188
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 9:20 AM ET
- Size
- 5.1 KB